Original Research
Bestis Wasef, PharmD, BCOP; Kelly Fritz, PharmD, BCOP; Courtney C. Cavalieri, PharmD, BCOP
Jenny McCabe, PharmD; Amanda Al-Bahou, PharmD, BCOP; Leann Koontz, PharmD, BCPS, BCOP;
Linda Linderbeck, PharmD, BCOP; Michael Verbosky, PharmD, BCPS; Michelle Prieto, PharmD
Belinda Li, PharmD, BCOP; Laura Beth Parsons, PharmD, BCOP; Darby Siler, PharmD, BCOP;
Rachel Matthews, PharmD, BCOP
Allison P. Golbach, PharmD; Jodi L. Taraba, PharmD; Matthew D. Smith, PharmD; Kristin C. Mara, MS;
Karthik V. Giridhar, MD
Nicholas J. Newman, PharmD; Sara E. Gordon, PharmD, BCOP; Charles J. Nock, MD; Christopher J. Burant, PhD; Candice M. Wenzell, PharmD, BCOP
Jessica Marini, PharmD, BCOP; Bailey Bass Hammond, PharmD; Jacob Rennebaum, PharmD;
Erin Weeda, PharmD, BCPS; Jagoda Misniakiewicz, PharmD; Amy Sion, PharmD, BCOP
Emily H. Hsu, PharmD, and Ryan Beechinor, PharmD, BCPS, BCOP
Reduced Starting Dose of Tyrosine Kinase Inhibitors in Patients with Metastatic Renal-Cell Carcinoma
Tia M. Stitt, PharmD; Katherine M. Saunders, PharmD, BCOP; Brooke C. Rowling, PharmD Candidate; Jennifer L. Waller, PhD; Amber B. Clemmons, PharmD, BCOP, FHOPA
Jacqueline Saunders, PharmD, BCPS; Sumati Murli, PhD; Michelle A. Rudek, PharmD, PhD;
Anand Khandoobhai, PharmD, MS; Anne DeLisa, PharmD, CCRP; Amy Goodrich, RN, MSN, CRNP-AC;
Janet Mighty, BS Pharm, MBA
Trace Bartels, PharmD; Molly Klanderman, PhD, MS; Jaime Rogers, MSN, RN; Kristin Gray, MSN, RN; Heidi Kosiorek, MS; Chris Coughlin, PharmD, BCOP